SPONSOR
Ayal A. Aizer, MD
Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases, AdultBrain Metastases From Extra-cranial Solid TumorsBrain Tumor - Metastatic
Ayal A. Aizer, MD is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Seizures, Primary Motor Cortex, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases, Adult.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ayal A. Aizer, MD
How many clinical trials has Ayal A. Aizer, MD sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Ayal A. Aizer, MD, of which 2 are actively recruiting participants. These trials cover conditions including Seizures, Primary Motor Cortex, Brain Metastases From Non-small Cell Lung Cancer (NSCLC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ayal A. Aizer, MD research focus on?
Ayal A. Aizer, MD clinical trials span Seizures, Primary Motor Cortex, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases, Adult, Brain Metastases From Extra-cranial Solid Tumors, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ayal A. Aizer, MD clinical trial?
To participate in a Ayal A. Aizer, MD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ayal A. Aizer, MD trials with current recruitment status updated daily.
Clinical Trials by Ayal A. Aizer, MD
NCT07130786 Phase 2
Recruiting
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Seizures
NCT07132190 Phase 2
Recruiting
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
Brain Metastases, Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology